ATE232907T1 - Enantiosektive herstellung pharmazeutisch aktiver sulfoxide durch biooxidation - Google Patents
Enantiosektive herstellung pharmazeutisch aktiver sulfoxide durch biooxidationInfo
- Publication number
- ATE232907T1 ATE232907T1 AT95939460T AT95939460T ATE232907T1 AT E232907 T1 ATE232907 T1 AT E232907T1 AT 95939460 T AT95939460 T AT 95939460T AT 95939460 T AT95939460 T AT 95939460T AT E232907 T1 ATE232907 T1 AT E232907T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- pharmaceutically active
- enantiosective
- biooxidation
- production
- Prior art date
Links
- 150000003462 sulfoxides Chemical class 0.000 title abstract 2
- DJXCWHRLBUYJFH-UHFFFAOYSA-N 2-pyridin-2-ylsulfinyl-1h-benzimidazole Chemical class N=1C2=CC=CC=C2NC=1S(=O)C1=CC=CC=N1 DJXCWHRLBUYJFH-UHFFFAOYSA-N 0.000 abstract 1
- 108091006112 ATPases Proteins 0.000 abstract 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 150000003568 thioethers Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9423970A GB9423970D0 (en) | 1994-11-28 | 1994-11-28 | Oxidation |
| PCT/SE1995/001415 WO1996017076A1 (en) | 1994-11-28 | 1995-11-27 | Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE232907T1 true ATE232907T1 (de) | 2003-03-15 |
Family
ID=10765078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95939460T ATE232907T1 (de) | 1994-11-28 | 1995-11-27 | Enantiosektive herstellung pharmazeutisch aktiver sulfoxide durch biooxidation |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5840552A (de) |
| EP (1) | EP0795024B1 (de) |
| JP (1) | JP3684576B2 (de) |
| AT (1) | ATE232907T1 (de) |
| AU (1) | AU699577B2 (de) |
| CA (1) | CA2203999A1 (de) |
| DE (1) | DE69529686T2 (de) |
| DK (1) | DK0795024T3 (de) |
| ES (1) | ES2191066T3 (de) |
| GB (1) | GB9423970D0 (de) |
| WO (1) | WO1996017076A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE504459C2 (sv) * | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
| GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
| GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
| SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
| AU746706B2 (en) * | 1997-07-03 | 2002-05-02 | Du Pont Pharmaceuticals Company | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
| SE9900274D0 (sv) | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
| AU6727700A (en) * | 1999-08-25 | 2001-03-19 | Takeda Chemical Industries Ltd. | Process for the preparation of optically active sulfoxide derivatives |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| ES2273829T3 (es) * | 2000-04-28 | 2007-05-16 | Takeda Pharmaceutical Company Limited | Procedimiento para producir derivado de sulfoxido opticamente activo. |
| DE10254167A1 (de) | 2002-11-20 | 2004-06-09 | Icon Genetics Ag | Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen |
| RS52667B (en) | 2002-12-06 | 2013-06-28 | Nycomed Gmbh | PROCEDURE FOR PREPARING OPTICALLY CLEAN UNITS |
| BR0316702A (pt) | 2002-12-06 | 2005-10-18 | Altana Pharma Ag | xprocesso para preparação de (s)-pantoprazol |
| EP1801110A1 (de) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Argininsalz des Esomeprazols |
| WO2008004245A1 (en) | 2006-07-05 | 2008-01-10 | Lupin Limited | Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds |
| SG181535A1 (en) | 2009-12-08 | 2012-07-30 | Codexis Inc | Synthesis of prazole compounds |
| CZ302612B6 (cs) * | 2010-11-01 | 2011-08-03 | Zentiva, K.S. | Kmen mikroorganismu Bacillus sp. B71 CCM 7718 |
| DK2649187T3 (da) | 2010-12-08 | 2018-01-29 | Codexis Inc | Biokatalysatorer og fremgangsmåder til syntesen af armodafinil |
| CN108239618A (zh) * | 2016-12-23 | 2018-07-03 | 浙江京新药业股份有限公司 | 共表达环己酮单加氧酶和异丙醇脱氢酶的基因工程菌及其应用 |
| CN108251466B (zh) * | 2016-12-28 | 2021-07-02 | 浙江京新药业股份有限公司 | 一种酶法合成埃索美拉唑的方法 |
| CN107418923B (zh) | 2017-09-20 | 2018-03-23 | 华东理工大学 | 伯克霍尔德菌及其应用 |
| FR3097234B1 (fr) * | 2019-06-17 | 2021-06-18 | Arkema France | Procede selectif de preparation de sulfoxydes par catalyse enzymatique |
| CN113461663B (zh) * | 2020-03-30 | 2023-11-28 | 江苏奥赛康药业有限公司 | 一种质子泵抑制剂艾司奥美拉唑钠的膜分离纯化方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US5049674A (en) * | 1989-12-20 | 1991-09-17 | Aktiebolaget Hassle | Therapeutically active fluoro substituted benzimidazoles |
| EP0593463B1 (de) * | 1990-06-20 | 1999-09-15 | Astra Aktiebolag | Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung |
| DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
| TNSN95062A1 (fr) * | 1994-05-27 | 1996-02-06 | Astra Ab | Nouveaux derives dialkoxy-pyridinyle-benzimidazole |
| TNSN95063A1 (fr) * | 1994-05-27 | 1996-02-06 | Astra Ab | Nouveaux benzimidazoles substitues |
| GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
-
1994
- 1994-11-28 GB GB9423970A patent/GB9423970D0/en active Pending
-
1995
- 1995-11-27 EP EP95939460A patent/EP0795024B1/de not_active Expired - Lifetime
- 1995-11-27 US US08/569,114 patent/US5840552A/en not_active Expired - Lifetime
- 1995-11-27 DE DE69529686T patent/DE69529686T2/de not_active Expired - Fee Related
- 1995-11-27 DK DK95939460T patent/DK0795024T3/da active
- 1995-11-27 AT AT95939460T patent/ATE232907T1/de not_active IP Right Cessation
- 1995-11-27 ES ES95939460T patent/ES2191066T3/es not_active Expired - Lifetime
- 1995-11-27 CA CA002203999A patent/CA2203999A1/en not_active Abandoned
- 1995-11-27 WO PCT/SE1995/001415 patent/WO1996017076A1/en active IP Right Grant
- 1995-11-27 JP JP51866996A patent/JP3684576B2/ja not_active Expired - Fee Related
- 1995-11-27 AU AU41269/96A patent/AU699577B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10510705A (ja) | 1998-10-20 |
| DE69529686D1 (de) | 2003-03-27 |
| AU4126996A (en) | 1996-06-19 |
| JP3684576B2 (ja) | 2005-08-17 |
| DK0795024T3 (da) | 2003-04-22 |
| GB9423970D0 (en) | 1995-01-11 |
| ES2191066T3 (es) | 2003-09-01 |
| AU699577B2 (en) | 1998-12-10 |
| WO1996017076A1 (en) | 1996-06-06 |
| DE69529686T2 (de) | 2004-01-15 |
| EP0795024B1 (de) | 2003-02-19 |
| CA2203999A1 (en) | 1996-06-06 |
| US5840552A (en) | 1998-11-24 |
| EP0795024A1 (de) | 1997-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69529686D1 (de) | Enantiosektive herstellung pharmazeutisch aktiver sulfoxide durch biooxidation | |
| NO994722D0 (no) | Ernæringsformuleringer inneholdende Lacto-N-neotetraose | |
| ATE456648T1 (de) | Verfahren zur herstellung von l-aminosäure | |
| IT1260468B (it) | Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole | |
| NO20083728L (no) | Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid | |
| FR2706767B1 (de) | ||
| DE68925002D1 (de) | Verfahren zur Herstellung von optisch-aktiven alpha-substituierten organischen Säuren und Mikroorganismen und Enzyme, die dafür verwendet werden. | |
| ATE203019T1 (de) | Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane | |
| DK0756454T3 (da) | Sammensætning og fremgangsmåde til bekæmpelse af plantesygdomme | |
| DE69632199T2 (de) | Verfahren zur herstellung von d-pantoinsäure und d-pantothensäure oder deren salze | |
| HK1059439A1 (en) | Compounds having activity as inhibitors of cytochrome p450rai | |
| PT795604E (pt) | Estirpes de bacterias com metabolismo alterado de acidos biliares e sua utilizacao | |
| DE69203718D1 (de) | Enzymatische reverse-hydrolyse von hydrophilen substraten; herstellung von amphiphilen verbindungen. | |
| AU1539695A (en) | Bacterial strains of genus (bacillus) closely phenotypically related to genus (lactobacillus), culture method and use | |
| ATE224149T1 (de) | Verfahren zur herstellung von stabilen trüben extrakten | |
| AU4174496A (en) | Silylation process | |
| NO990159L (no) | FremgangsmÕte for fremstilling av enantiomerisk anrikede N-acylazetidin-2-karboksylsyrer | |
| ATE341630T1 (de) | Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin | |
| DE69902999D1 (de) | Glucocorticoide zur behandlung von glomerulonephitis | |
| DE59914749D1 (de) | Ustilipide, verfahren zu deren herstellung sowie deren verwendung | |
| DK0777663T3 (da) | Anvendelse af substituerede 6-amino-4H-pyraner | |
| ATE262279T1 (de) | Insektizide enzyme | |
| ECSP982392A (es) | Nuevos compuestos | |
| KR930013101A (ko) | 프락토실트랜스퍼라제 및 β- 갈락토시다제의 제조방법 | |
| AU5269696A (en) | Anellated beta-carbolines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0795024 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |